Skip to content
Abierto

Award notice

Center for Biologics Evaluation and Research (CBER), Biologics Effectiveness and Safety (BEST) Initiative #3: Data Sources for Surveillance of Biologics

75F40124R00002-CVS

Food and Drug Administration, FDA Office of Acq Grant SVCS. Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services.

Awarded

CVS Healthspire Payor & Life Sciences LLC

$75,000,000.00 on the award notice, September 27, 2024, contract 75F40124D00042

Description

As published on SAM.gov.

Multiple Award Indefinite Delivery / Indefinite Quantity (ID/IQ) contract for the Food and Drug Administration (FDA), Center for Biologics Evaluation and Research (CBER), Biologics Effectiveness and Safety (BEST)

Initiative #3: Health Care Data Sources for Surveillance of Biologics (BEST 3). $75,000,000.00 IDIQ ceiling for each contract.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

UEI
CNYSJ3KBMW97
CAGE
8N570
Vendor location
Hartford, CT
Contract
75F40124D00042
Obligated
$10,000.00, potential $75,000,000
Actions
2 between September 27, 2024 and June 11, 2025
Competition
Full and Open Competition, 8 offers received
Set-aside reported
No Set Aside Used.
Described as
Center for Biologics Evaluation and Research (Cber) Requirement for Biologics Effectiveness and Safety (Best) Initiative #3: Health Care Data Sources for Surveillance of Biologics (Best 3)
Match
award number 75F40124D00042 equals the contract number; same awarding office 75F401 (high confidence)

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. September 27, 2024

    Award notice, originally solicitation

    Awarded to CVS HEALTH CLINICAL TRIAL SERVICES LLC Hartford for $75,000,000. SAM.gov, notice bd71d8bde7e94827ab3815230588d9d4

Points of contact